Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System (ASR)
Primary Purpose
Non-inflammatory Degenerative Joint Disease
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ASR™-XL Modular Acetabular Cup System
Pinnacle™ acetabular shell
Sponsored by
About this trial
This is an interventional treatment trial for Non-inflammatory Degenerative Joint Disease focused on measuring Hip arthroplasty, Acetabular cup replacement, Acetabulum arthroplasty
Eligibility Criteria
Inclusion Criteria:
- Subject is able to or capable of providing consent to participate in the clinical investigation.
- Subject is between the ages of 20-75 years, inclusive.
- Subject requires a cementless, primary total hip arthroplasty for non-inflammatory degenerative joint disease (NIDJD).
- Subject has sufficient bone stock for the hip replacement device.
- Subject is a suitable candidate for the devices specified in the clinical investigation plan and is willing to be randomized to either cup system device.
Exclusion Criteria:
- Subject, in the opinion of the Investigator, has an existing condition that would compromise his/her participation and follow-up in this investigation.
- Subject with a known allergy to metal (e.g. jewelry).
- Subject has inflammatory arthritis (e.g. rheumatoid arthritis).
- Subject has active or recent joint sepsis.
- Subject with marked atrophy or deformity in the upper femur.
- Subject with a neuromuscular disease where the loss of musculature would affect functional outcome.
- Subject, in the opinion of the Clinical Investigator, has a history of chronic renal insufficiency (e.g. dialysis).
- Subject is receiving systemic steroid therapy, excluding inhalers or intra-capsular injections, within 3 months prior to surgery.
- Subject with known, active metastatic or neoplastic disease.
- Subject is known to be pregnant, a prisoner, mentally incompetent, and or alcohol or drug abuser.
- Subject is currently involved in any personal injury litigation, medical legal or worker's compensation claims.
Sites / Locations
- Desert Orthopaedics
- Resurgens Orthopaedics
- Illinois Bone and Joint Institute
- Spectrum Health Hospital Research
- Dartmouth-Hitchcock Medical Center
- Eastern Oklahoma Orthopedic Center
- Orthopaedic Specialists of Austin
- Valley Orthopaedic Associates
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
A
B
Arm Description
ASR™-XL Modular Acetabular Cup System stem
Pinnacle™ acetabular shell, with a 28mm or 36mm ULTAMET® metal liner, and a 28mm or 36mm Articul/eze M head.
Outcomes
Primary Outcome Measures
Composite Success Based Upon Harris Hip Score, Radiographic and Survivorship Outcomes
"Composite success: 1) Revision free (life of study) 2) No evidence of radiographic failure (life of study) 3) Harris Hip score => 80 at 24 months"
Secondary Outcome Measures
T-Test of Harris Hip Total Score Means at 24 Months
T-Test of Harris Hip total score means at 24 months
Harris Hip Pain Sub Score at 24 Months
Mean Harris Hip Pain sub score
Harris Hip Function Score at 24 Months
Mean Harris Hip Function sub score at 24 months
Analysis of Metal Ion Release - Serum Cobalt
Serum Cobalt
Analysis of Metal Ion Release - Serum Chromium
Serum Chromium
Analysis of Metal Ion Release - Erythrocyte Cobalt
Erythrocyte cobalt
Analysis of Metal Ion Release - Erythrocyte Chromium
Erythrocyte Chromium
Analysis of Metal Ion Release - Serum Cobalt
Serum Cobalt
Analysis of Metal Ion Release - Serum Chromium
Serum Chromium
Analysis of Metal Ion Release - Erythrocyte Cobalt
Erythrocyte Cobalt
Analysis of Metal Ion Release - Erythrocyte Chromium
Erythrocyte Chromium
Analysis of Metal Ion Release - Serum Cobalt
Serum Cobalt
Analysis of Metal Ion Release - Serum Chromium
Serum Chromium
Analysis of Metal Ion Release - Erythrocyte Cobalt
Erythrocyte Cobalt
Analysis of Metal Ion Release - Erythrocyte Chromium
Erythrocyte Chromium
Analysis of Metal Ion Release - Serum Cobalt
Serum Cobalt
Analysis of Metal Ion Release - Serum Chromium
Serum Chromium
Analysis of Metal Ion Release - Erythrocyte Cobalt
Erythrocyte Cobalt
Analysis of Metal Ion Release - Erythrocyte Chromium
Erythrocyte Chromium
Analysis of Metal Ion Release - Serum Cobalt
Serum Cobalt
Analysis of Metal Ion Release - Serum Chromium
Serum Chromium
Analysis of Metal Ion Release - Erythrocyte Cobalt
Erythrocyte cobalt
Analysis of Metal Ion Release - Erythrocyte Chromium
Erythrocyte chromium
Analysis of Metal Ion Release - Serum Cobalt
Serum Cobalt
Analysis of Metal Ion Release - Serum Chromium
Serum Chromium
Analysis of Metal Ion Release - Erythrocyte Cobalt
Erythrocyte Cobalt
Analysis of Metal Ion Release - Erythrocyte Chromium
Erythrocyte chromium
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00561600
Brief Title
Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System
Acronym
ASR
Official Title
A Randomized, Prospective, Comparative, Multi-Center Clinical Evaluation of the DePuy ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
November 1, 2006 (Actual)
Primary Completion Date
January 1, 2012 (Actual)
Study Completion Date
January 1, 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
DePuy Orthopaedics
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this investigation is to evaluate the clinical and radiographic outcomes of the ASR™-XL Acetabular Cup System compared to the Pinnacle™ Acetabular Cup with a 28mm or 36mm ULTAMET™ metal insert.
Detailed Description
The purpose of this clinical investigation is to gather sufficient clinical and radiographic data to permit valid scientific comparisons between treatment and control group outcomes. The treatment group/device for this study is the ASR™-XL Acetabular Cup System, and the control group/device is the Pinnacle™ Cup System w/ the 28mm or 36mm ULTAMET™ metal liner. The study objective will be achieved by way of treatment group selection, treatment administration, and management of participating study Subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-inflammatory Degenerative Joint Disease
Keywords
Hip arthroplasty, Acetabular cup replacement, Acetabulum arthroplasty
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
265 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Active Comparator
Arm Description
ASR™-XL Modular Acetabular Cup System stem
Arm Title
B
Arm Type
Active Comparator
Arm Description
Pinnacle™ acetabular shell, with a 28mm or 36mm ULTAMET® metal liner, and a 28mm or 36mm Articul/eze M head.
Intervention Type
Device
Intervention Name(s)
ASR™-XL Modular Acetabular Cup System
Other Intervention Name(s)
Acetabular cup replacement
Intervention Description
The ASR™-XL Modular Acetabular Cup System treatment device is comprised of a metal acetabular cup, a unipolar femoral head and a taper sleeve adapter.
Intervention Type
Device
Intervention Name(s)
Pinnacle™ acetabular shell
Other Intervention Name(s)
Acetabular cup replacement
Intervention Description
The Pinnacle™ shells are cementless, titanium alloy cups with Porocoat® porous coating and HA DuoFix™ coating. There are various different liners available for use with the Pinnacle™ Acetabular Cup System. For the purpose of this investigation, the CoCrMo ULTAMET® 28mm or 36 mm metal liners will be used.
Primary Outcome Measure Information:
Title
Composite Success Based Upon Harris Hip Score, Radiographic and Survivorship Outcomes
Description
"Composite success: 1) Revision free (life of study) 2) No evidence of radiographic failure (life of study) 3) Harris Hip score => 80 at 24 months"
Time Frame
24-month interval.
Secondary Outcome Measure Information:
Title
T-Test of Harris Hip Total Score Means at 24 Months
Description
T-Test of Harris Hip total score means at 24 months
Time Frame
24 months
Title
Harris Hip Pain Sub Score at 24 Months
Description
Mean Harris Hip Pain sub score
Time Frame
24 months
Title
Harris Hip Function Score at 24 Months
Description
Mean Harris Hip Function sub score at 24 months
Time Frame
24 months
Title
Analysis of Metal Ion Release - Serum Cobalt
Description
Serum Cobalt
Time Frame
Pre-operative
Title
Analysis of Metal Ion Release - Serum Chromium
Description
Serum Chromium
Time Frame
pre-operative
Title
Analysis of Metal Ion Release - Erythrocyte Cobalt
Description
Erythrocyte cobalt
Time Frame
pre-operative
Title
Analysis of Metal Ion Release - Erythrocyte Chromium
Description
Erythrocyte Chromium
Time Frame
Pre-operative
Title
Analysis of Metal Ion Release - Serum Cobalt
Description
Serum Cobalt
Time Frame
4 months post-operative
Title
Analysis of Metal Ion Release - Serum Chromium
Description
Serum Chromium
Time Frame
4 months post operative
Title
Analysis of Metal Ion Release - Erythrocyte Cobalt
Description
Erythrocyte Cobalt
Time Frame
4 months post-operative
Title
Analysis of Metal Ion Release - Erythrocyte Chromium
Description
Erythrocyte Chromium
Time Frame
4 months post-operative
Title
Analysis of Metal Ion Release - Serum Cobalt
Description
Serum Cobalt
Time Frame
12 months post-operative
Title
Analysis of Metal Ion Release - Serum Chromium
Description
Serum Chromium
Time Frame
12 Months
Title
Analysis of Metal Ion Release - Erythrocyte Cobalt
Description
Erythrocyte Cobalt
Time Frame
12 Months
Title
Analysis of Metal Ion Release - Erythrocyte Chromium
Description
Erythrocyte Chromium
Time Frame
12 months
Title
Analysis of Metal Ion Release - Serum Cobalt
Description
Serum Cobalt
Time Frame
24 months
Title
Analysis of Metal Ion Release - Serum Chromium
Description
Serum Chromium
Time Frame
24 months
Title
Analysis of Metal Ion Release - Erythrocyte Cobalt
Description
Erythrocyte Cobalt
Time Frame
24 months
Title
Analysis of Metal Ion Release - Erythrocyte Chromium
Description
Erythrocyte Chromium
Time Frame
24 months
Title
Analysis of Metal Ion Release - Serum Cobalt
Description
Serum Cobalt
Time Frame
36 months
Title
Analysis of Metal Ion Release - Serum Chromium
Description
Serum Chromium
Time Frame
36 months
Title
Analysis of Metal Ion Release - Erythrocyte Cobalt
Description
Erythrocyte cobalt
Time Frame
36 months
Title
Analysis of Metal Ion Release - Erythrocyte Chromium
Description
Erythrocyte chromium
Time Frame
36 months
Title
Analysis of Metal Ion Release - Serum Cobalt
Description
Serum Cobalt
Time Frame
48 months
Title
Analysis of Metal Ion Release - Serum Chromium
Description
Serum Chromium
Time Frame
48 months
Title
Analysis of Metal Ion Release - Erythrocyte Cobalt
Description
Erythrocyte Cobalt
Time Frame
48 months
Title
Analysis of Metal Ion Release - Erythrocyte Chromium
Description
Erythrocyte chromium
Time Frame
48 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject is able to or capable of providing consent to participate in the clinical investigation.
Subject is between the ages of 20-75 years, inclusive.
Subject requires a cementless, primary total hip arthroplasty for non-inflammatory degenerative joint disease (NIDJD).
Subject has sufficient bone stock for the hip replacement device.
Subject is a suitable candidate for the devices specified in the clinical investigation plan and is willing to be randomized to either cup system device.
Exclusion Criteria:
Subject, in the opinion of the Investigator, has an existing condition that would compromise his/her participation and follow-up in this investigation.
Subject with a known allergy to metal (e.g. jewelry).
Subject has inflammatory arthritis (e.g. rheumatoid arthritis).
Subject has active or recent joint sepsis.
Subject with marked atrophy or deformity in the upper femur.
Subject with a neuromuscular disease where the loss of musculature would affect functional outcome.
Subject, in the opinion of the Clinical Investigator, has a history of chronic renal insufficiency (e.g. dialysis).
Subject is receiving systemic steroid therapy, excluding inhalers or intra-capsular injections, within 3 months prior to surgery.
Subject with known, active metastatic or neoplastic disease.
Subject is known to be pregnant, a prisoner, mentally incompetent, and or alcohol or drug abuser.
Subject is currently involved in any personal injury litigation, medical legal or worker's compensation claims.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dave Whalen, BS, DC
Organizational Affiliation
DePuy Orthopaedics
Official's Role
Study Director
Facility Information:
Facility Name
Desert Orthopaedics
City
Rancho Mirage
State/Province
California
ZIP/Postal Code
92270
Country
United States
Facility Name
Resurgens Orthopaedics
City
Cumming
State/Province
Georgia
ZIP/Postal Code
30041
Country
United States
Facility Name
Illinois Bone and Joint Institute
City
Morton Grove
State/Province
Illinois
ZIP/Postal Code
60053
Country
United States
Facility Name
Spectrum Health Hospital Research
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49503-2550
Country
United States
Facility Name
Dartmouth-Hitchcock Medical Center
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03756-0001
Country
United States
Facility Name
Eastern Oklahoma Orthopedic Center
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74136
Country
United States
Facility Name
Orthopaedic Specialists of Austin
City
Austin
State/Province
Texas
ZIP/Postal Code
78705
Country
United States
Facility Name
Valley Orthopaedic Associates
City
Renton
State/Province
Washington
ZIP/Postal Code
98055-5791
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System
We'll reach out to this number within 24 hrs